Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference
Stock Information for Acurx Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.